neurolens Announces the nMD2

Coppell, Texas, March 29, 2021 – In the spirit of continual eye care innovation, neurolens has announced the launch today of the neurolens Measurement Device, Gen 2 (nMD2). The nMD2 will be commercially available on July 1, 2021, but neurolens will starting taking orders immediately as part of a pre-sale offer. The nMD2 is an objective, accurate and repeatable way to measure binocular vision; or, more specifically, eye alignment. Employing over 10,000 data points per patient, the cutting-edge eye tracking system can identify eye misalignment as small as 0.1 Prism Diopters. The diagnostic information from the nMD2 is used to prescribe neurolenses with patented Contoured Prism technology, which bring the eyes into alignment, relieving the headaches, neck and shoulder pain, eye strain, dry eye and dizziness that many people experience when using their near vision.

Read the remainder of the press release here on the company’s website or a PDF archive copy of the story here.

Shared by Steve Kirby, board member of Neurolens.